Showing results (1851-1860 of 3,529) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|May 6, 2020
CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivoKun Zhang, Lili Wang, Aili Wei, et al.
Thoracic Cancer|May 7, 2020
Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancerMaik Häntschel, Johannes Niebling, Almut Häring, et al.
Thoracic Cancer|May 7, 2020
Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case reportYuxin Sun, Chi Shao, Kai Xu, et al.
Thoracic Cancer|May 7, 2020
LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5pShuqin Zhang, Bin Wang, Huiwen Xiao, et al.
Thoracic Cancer|May 13, 2020
Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancerMing-Jenn Chen, Po-Lin Lin, Lee Wang, et al.
Thoracic Cancer|April 15, 2020
Combination of electromagnetic navigation bronchoscopy-guided microwave ablation and thoracoscopic resection: An alternative for treatment of multiple pulmonary nodulesNing Jiang, Liming Zhang, Yingtao Hao, et al.
Thoracic Cancer|April 29, 2020
Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patientsPeng Song, Dongliang Yang, Hanping Wang, et al.
Thoracic Cancer|April 21, 2020
Opportunistic infections complicating immunotherapy for non-small cell lung cancerZiwei Liu, Tao Liu, Xiaotong Zhang, et al.
Thoracic Cancer|April 14, 2020
Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancerChia-Hsun Chu, Tzu-Hsuan Chiu, Chin-Chou Wang, et al.
Thoracic Cancer|October 25, 2019
Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinomaTaehee Kim, Eun Young Kim, Sang Hoon Lee, et al.
Pageof 353